97 results on '"Steinhubl, Steven"'
Search Results
2. Abstract 14239: Development and Validation of a Daily Measure of Cardiorespiratory Fitness - Estimated Vo2Max - Using Multiparametric Data From a Wearable Sensor
3. Abstract 10560: Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The Mhealth Screening to Prevent Strokes Study
4. Abstract 17189: Explaining the Deep Learning Black Box by Identifying Segments of the Single-Lead ECG Signal Used for Detection of Atrial Fibrillation
5. Advanced and Accurate Mobile Health Tracking Devices Record New Cardiac Vital Signs
6. Characteristics of the modern-day physician house call
7. Advanced and Accurate Mobile Health Tracking Devices Record New Cardiac Vital Signs
8. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
9. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis
10. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study
11. Abstract 18682: Short-term Decrease in Home Blood Pressure: Implications of Waiting Few Minutes Between Measurements
12. Abstract 18610: Preliminary Evaluation of a Wrist Wearable Heart Rate Sensor for the Detection of Undiagnosed Atrial Fibrillation in a Real-World Setting
13. Abstract 18562: Inter-individual Variation in Duration, Frequency and Burden of Paroxysmal Atrial Fibrillation in 13,350 Individuals Undergoing Extended Cardiac Rhythm Monitoring
14. Abstract 13757: A Nationwide Trial of Screening for Undiagnosed Atrial Fibrillation in an At-Risk Population Using a Self-Applied ECG Recording Patch Sensor: Results of the Randomized Component of the mHealth Screening to Prevent Strokes (mSToPS) Trial
15. Digital technology to enable aging in place
16. Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial
17. Outcomes in Adults With Acute Pulmonary Embolism Who Are Discharged From Emergency Departments: The Cardiovascular Research Network Venous Thromboembolism Study
18. Digital Medical Tools and Sensors
19. Implementation of Mobile Health Tools—Reply
20. Can Mobile Health Technologies Transform Health Care?
21. A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
22. Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model
23. Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model
24. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
25. Oral fluids that detect cardiovascular disease biomarkers
26. Oral fluids that detect cardiovascular disease biomarkers
27. Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
28. Is a higher loading dose of clopidogrel more effective during primary angioplasty for patients with STEMI?
29. Being Successful at Prevention: Making It Easy to Do the Right Thing: Comment on “Improving Care After Myocardial Infarction Using a 2-Year Internet-Delivered Intervention”
30. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial
31. Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy
32. Corrigendum to “Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?” [Pharmacol. Ther. 127(2) (2010) 95–107]
33. Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?
34. Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention
35. Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist
36. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
37. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry
38. Aspirin following PCI: too much of a good thing?
39. The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease
40. Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
41. Cangrelor in percutaneous coronary intervention
42. Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial
43. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
44. Determining the efficacy of antiplatelet therapies for the individual: Lessons from clinical trials
45. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use
46. Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease: The STRADIVARIUS Randomized Controlled Trial
47. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
48. Vulnerable Plaque Intervention: State of The Art
49. Atrial fibrillation in the setting of acute myocardial infarction —irregularly irregular treatment
50. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.